Search

The difficulties of energy R&D

Memo to governments: Energy research is different than that in other sectors – longer term, more costly, higher hurdles to market.

Maybe Europe’s pharma sector can save itself

As the second tranche of projects in the €2 billion Innovative Medicines Initiative was announced this week, a quick stock take of progress to date hints at what this wide-ranging collaboration could deliver